DR. JEFFREY TODD LANDIS M.D. NPI 1528155439

NPI Information

  • NPI: 1528155439
  • Provider Name: DR. JEFFREY TODD LANDIS, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 700 GEIPE RD
    SUITE 200
    CATONSVILLE, MD
    ZIP 21228
  • Phone: (410) 744-0661

Map and Directions

Get Directions

NPI Details

DR. Jeffrey Todd Landis, M.D. is a rheumatology internal medicine in Catonsville, MD with 21 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Jeffrey Todd Landis, M.D. NPI is 1528155439. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

700 GEIPE RD
SUITE 200
CATONSVILLE, MD
ZIP 21228-147
Phone: (410) 744-0661
Fax: (410) 744-8036

The NPI 1528155439 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Complete ultrasound scan of joint (HCPCS:76881)
  • Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Acute hepatitis panel (HCPCS:80074)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Vitamin d-3 level (HCPCS:82306)
  • Rheumatoid factor level (HCPCS:86431)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Uric acid level, blood (HCPCS:84550)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
  • Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
  • Ultrasonic guidance for needle placement (HCPCS:76942)
  • Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection into tendon or ligament (HCPCS:20550)
  • Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
  • Fee covid-19 vac 14 res (HCPCS:0134A)

The enumeration date for this NPI number is 10/10/2006 and was last updated on 3/4/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyD0070317MARYLANDYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.